Since October, when Eli Lilly and Co. announced it was reviewing whether to sell or spin off Elanco, Greenfield city leaders have been wondering what the future holds for the city’s economy.
Darshan Shah is Indiana’s first chief data officer. In that role, he leads the Indiana Management Performance Hub and coordinates resources to guide policymakers in addressing the opioid epidemic, optimizing Medicaid services, and enhancing Indiana’s education-to-workforce pipeline.
Serving as national president of the Black Data Processing Association and as a trustee and deacon for his church, Terry J. Morris is one of Lilly’s leading tech lights.
Leaving corporate life to found her own marketing business—at age 24—Tiffany Sauder grew her startup to 72 employees and nearly $10 million in revenue with clients that include Airstream and BraunAbility.
Strong jobs data that increased the likelihood the Federal Reserve will lift rates next month rattled equity investors who haven’t seen a week this bad in two years.
As many as 130,000 of the 400,000 people now covered by the Healthy Indiana Plan 2.0 will be required to work, take part in school or training, or do community service to continue receiving insurance benefits in 2019.
Barely two weeks after being confirmed as U.S. Secretary for Health and Human Services, former Eli Lilly and Co. executive Alex Azar is returning to Indianapolis on Friday for an announcement with state officials.
A hulking retail property pocked with vacancies sends a terrible message about Indianapolis’ vitality to the throngs of conventioneers who walk its corridors.
The Indianapolis-based drug company took a $1 billion charge for its sweeping early-retirement program and a $2.9 billion charge to repatriate cash in the wake of Congress' passage of tax reform.
President Donald Trump's second health secretary won Senate approval Wednesday, clearing the way for former Eli Lilly and Co. executive Alex Azar to take over a sprawling department shaken by his predecessor's early exit.
Corporate America, including some of Indiana’s top executives, implored Congress to give it a tax cut—a move businesses said would translate into more U.S. jobs and investment. Now that’s occurred.
More deals could be on the horizon as dozens of companies—including local powerhouses such as Simon, Eli Lilly and Anthem—game out what Amazon’s huge ambitions could mean for their bottom lines.
North American companies, which fell out of favor among acquirers last year, are back on the shopping list in 2018, making up almost 60 percent of all announced transactions in 2018.
A slimmed-down Eli Lilly and Co., thousands of employees lighter after its biggest restructuring in nearly a decade, is now looking high and low for deals to bulk up its drug pipeline.
Alex Azar, a former Eli Lilly and Co. executive, acknowledged to the Senate Finance Committee that drug prices are too high and said he'd work to lower them if confirmed as secretary of Health and Human Services.
Former Eli Lilly exec Alex Azar, who is President Donald Trump’s pick to lead the Department of Health and Human Services, faces senators at his second hearing on Capitol Hill on Tuesday.
Eli Lilly and Co. CEO Dave Ricks said Monday that the recent changes in U.S. tax policy will help the drugmaker lower its global tax burden as he continues to look for deals in areas like oncology.
